Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (190)

1

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

enthalten in: The New England journal of medicine | 2024

von Moser, C. | Li, J. | Hughes, M.

CommentOn: N Engl J Med. 2024 Jan 18;390(3):230-241. - PMID 38231624

2

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply

enthalten in: The New England journal of medicine | 2024

von Wang, Y. | Hu, H. | Cao, B.

CommentOn: N Engl J Med. 2024 Jan 18;390(3):230-241. - PMID 38231624

3

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

enthalten in: The New England journal of medicine | 2024

von Selvi-Sabater, P. | de la Rubia Ortí, J. | Urbieta-Sanz, E.

CommentOn: N Engl J Med. 2024 Jan 18;390(3):230-241. - PMID 38231624

4

In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes

enthalten in: Annals of internal medicine | 2024

von Chagla, Z.

CommentOn: Ann Intern Med. 2023 Oct;176(10):1377-1385. - PMID 37722115

5

UDCA treatment against COVID-19 : Do we have enough clinical evidence for drug repurposing?

enthalten in: Journal of internal medicine | 2024

von Ojeda-Fernández, L. | Baviera, M. | Macaluso, G. | +8

CommentOn: J Intern Med. 2023 May;293(5):636-647. - PMID 37018129

6

Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy

enthalten in: Annals of internal medicine | 2023

von Cohen, M. | Brown, E.

CommentOn: Ann Intern Med. 2023 Dec;176(12):1577-1585. - PMID 37956428

7

Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19

enthalten in: Annals of internal medicine | 2023

von Wan, E. | Yan, V. | Mok, A. | +2

CommentOn: Ann Intern Med. 2023 Apr;176(4):505-514. - PMID 36913693

8

Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19

enthalten in: Annals of internal medicine | 2023

von Focosi, D. | Nicastri, E.

CommentOn: Ann Intern Med. 2023 Apr;176(4):505-514. - PMID 36913693

9

The effect of molnupiravir on post-acute outcome of COVID-19 survivors

enthalten in: The Journal of infection | 2023

von Hsu, W. | Shiau, B. | Tsai, Y. | +4

CommentOn: J Infect. 2023 Feb;86(2):121-122. - PMID 36717180

10

Molnupiravir efficacy among immunocompromised patients with COVID-19 : no proof of concept

enthalten in: Infection | 2023

von Guermazi, D. | Arvanitis, P. | Farmakiotis, D.

CommentOn: Infection. 2023 Oct;51(5):1273-1284. - PMID 36648627

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]